Back to Journals » Journal of Pain Research » Volume 15

Lack of Neuromodulation Knowledge Among Rural Family Medicine Residents: A Call for Implementation Research

Authors Goree JH , Hayes C, Petersen E , Curran G

Received 30 December 2021

Accepted for publication 5 April 2022

Published 21 April 2022 Volume 2022:15 Pages 1183—1189

DOI https://doi.org/10.2147/JPR.S356416

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Dawood Sayed



Johnathan H Goree,1 Corey Hayes,2 Erika Petersen,3 Geoffrey Curran4

1Department of Anesthesiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 2Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 3Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 4Center for Implementation Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Correspondence: Johnathan H Goree, Department of Anesthesiology, University of Arkansas for Medical Sciences, 4301 W. Markham #515, Little Rock, AR, 72205, USA, Email [email protected]

Objective: Spinal cord stimulation is a proven, evidence-based therapy for persistent spinal pain syndrome. While some patients with this disease are managed by chronic pain physicians, many are managed in primary care offices. Despite mounting evidence, dissemination of this research outside of neuromodulation related fields and implementation of this treatment in common practice has not yet occurred. We hypothesize that family medicine residents in rural training programs will have little knowledge of neuromodulation despite it being an evidence-based and common treatment of post-laminectomy syndrome.
Materials and Methods: Online surveys were sent to family medicine residents in six rural family medicine training programs at the University of Arkansas for Medical Sciences Regional Programs to characterize knowledge of neuromodulation as a treatment for post-laminectomy syndrome.
Results: Forty-one percent of responding rural, Arkansas family medicine residents reported treating post-laminectomy syndrome during their training, yet only 10% have referred a patient for neuromodulation consultation. Residents rated their knowledge of neuromodulation/spinal cord stimulation at 19 on a scale of 0 (no knowledge) to 100 (extensive knowledge).
Conclusion: Despite proof that neuromodulation is an evidence-based treatment for post-laminectomy/failed back syndrome, rural family medicine residents have limited knowledge about the therapy and many do not consider a referral for neuromodulation. Further research to ascertain effective implementation strategies to increase the uptake of neuromodulation for patients with post-laminectomy syndrome is desperately needed.

Keywords: spinal cord stimulation, neuromodulation, rural, implementation science, dissemination

Introduction

The economic impact of chronic pain in the United States, including both medical care and loss of productivity, is approximately $635 billion dollars.1 While back pain composes the majority of these patients, 14.8% of patients with chronic back pain have a diagnosis of post-laminectomy syndrome.2 Post-laminectomy Syndrome (now referred to as persistent spine pain syndrome) is a disease of persistent and/or intermittent back pain with or without sciatica continuing for more than six months after a spine surgery.3–6 It is estimated to occur after 10% to 40% of lumbar spine operations and unfortunately, surgical success rate declines after each operative attempt.3,4,7

Spinal cord stimulation for the treatment of chronic back and leg pain has been discussed in the literature since 1965 after the groundbreaking report of the gate control theory of pain by Melzack and Wall.8 After the clinical introduction of this therapy by Shealy in 1967, extensive work has been conducted to not only refine and improve this technology but also to demonstrate its efficacious use in the treatment of challenging pain states.9 The evidence behind the use of spinal cord stimulation over medical management or spine reoperation for the treatment of neuropathic back and leg pain caused by post-laminectomy syndrome is well established.10–13 With recent improvements to technology including the introduction of high frequency, novel waveforms, and closed loop feedback mechanisms, outcomes are continuing to improve.13–15

Despite demonstrated superiority over medical management for the treatment of neuropathic back and leg pain, many believe that spinal cord stimulation is under-utilized in the treatment of post-laminectomy syndrome. Many factors contribute to the lack of use including access, payer status, lack of available providers, and lack of dissemination of knowledge of the technology. In rural states like Arkansas, these factors are most likely prominent. Despite evidence demonstrating a lack of efficacy and increase morbidity with the use of opioids for the treatment of most chronic pain disease states, opioids are routinely used.16,17 Per the CDC, Arkansas physicians prescribed 93.5 prescriptions per 100 persons in 2018, well above the national average of 51.4 for the same year.

To increase the availability of health care in the community, provide consultation and education for area health care professionals, and offer health education to individuals across Arkansas, The University of Arkansas for Medical Sciences has strategically placed family medicine residency programs in rural areas within seven of these eight regions of Arkansas to increase the number of primary care providers in rural areas of Arkansas as well as provide evidence-based healthcare for rural Arkansas. Due to this mission, the authors felt that the residents in these programs would be a good surrogate for knowledge among health providers in these rural communities.

With mounting evidence demonstrating benefit with spinal cord stimulation for the treatment of post-laminectomy syndrome, the purpose of this study is to assess the knowledge on this evidence among rural Arkansas family medicine residents and whether referrals for this treatment have been implemented into their practice. Our hypothesis is that rural Arkansas family medicine residents will have poor knowledge about spinal cord stimulation for the treatment of post-laminectomy syndrome and poor implementation of referrals for this treatment in their practice.

Methods

Study Design

This prospective survey study was approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (260602). Participants were administered an online survey consisting of 10 questions. The survey contained two question types: polar (yes/no) questions and linear number scale questions to allow rating of knowledge from a 0 (no knowledge) to 100 (extensive knowledge). Surveys were sent to the subjects via email and the survey was closed after fourteen days. A reminder email was sent to the subjects on day ten.

Subjects

The survey was sent to family medicine residents at UAMS' Regional Programs. UAMS is the only academic health center in Arkansas. To ensure adequate training of family medicine physicians across each of the areas of the state, UAMS divides Arkansas into nine regions. The UAMS Medical Center resides in the region of Central Arkansas in the Little Rock metropolitan area (population 734,622). This is the main population center of the state. The other eight regions contain UAMS Regional Program medical campuses (Figure 1).

Figure 1 A map of Arkansas divided by region with location of University of Arkansas for Medical Sciences (UAMS) regional programs.

Six of the rural Arkansas family medicine residency programs from the UAMS regional programs consented to be a part of this survey study. These sites are located in the following Arkansas cities/towns: Jonesboro, Texarkana, Pine Bluff, Magnolia, Fort Smith, and Batesville. The Northwest Arkansas Regional Center, which resides in the second largest population center in the state (Fayetteville/Bentonville/Springdale, AR metropolitan area – combined population 525,032), was excluded due to its suburban demographics. Table 1 shows the location of each of these programs, with the respective population size each serves, and the number of residents at each location. Family medicine residents at these six regional programs sites were provided with the internet-based, digital survey.

Table 1 Demographic Information of the Participating Sites. East Does Not Have a Resident Training Program and Northwest Declined Participation

Survey Development

The survey was developed to ascertain providers’ perceived knowledge about commonly prescribed or recommended chronic pain treatments. The survey also evaluated providers’ familiarity with post-laminectomy syndrome and other chronic pain therapies and how often they prescribe, recommend, or refer patients for these treatments in patients with post-laminectomy syndrome. Two of the authors (JG and CH) iteratively assessed the readability and acceptability of the survey questions. See Supplemental Document 1 for the full survey.

Analysis

Descriptive statistics were used to characterize the results of the survey. For polar questions, the number and percentage of residents was calculated for each response (yes/no). The mean, median, and standard deviation was calculated for each linear number scale question.

Results

Of the 115 rural, Arkansas family medicine residents contacted, 39 completed the digital survey, yielding a 34% completion rate. Of respondents, 41% stated they have treated a patient with post-laminectomy syndrome during their training. Only 10% of respondents have treated a patient with or referred a patient for neuromodulation/spinal cord stimulation. However, close to 66% of respondents stated they would refer a patient for neuromodulation in the future (Table 2). Other chronic pain therapies have wide-spread use among respondents including chronic opioid management (56%), Gabapentinoids/Antidepressants (46%), Epidural Steroid Injections (28%). Acupuncture (0%), Chiropractic Manipulation (5.13%), and Radiofrequency Ablation (7.69%) are recommended even less (Figure 2).

Table 2 Selected Yes/No Questions from Survey Presented to Rural Family Medicine Residents. For Ease of Presentation, We Shortened the Items. Full Survey Can Be Viewed in Supplemental Document 1

Figure 2 Graphic comparison of survey answers to “Which of the following therapies have you prescribed or referred a patient for who has chronic pain from failed back surgery syndrome/post-laminectomy syndrome?”

Among respondents, the mean rating of knowledge of neuromodulation was low, 18.66 on a scale of 0 to 100 (Table 3). This was only higher than chiropractic manipulation (14.00) and radiofrequency ablation (12.97). Responding rural, Arkansas family medicine residents rate their knowledge of neuromodulation lower than gabapentinoids/antidepressants (48.10), chronic opioid therapy (45.44), epidural steroid injections (29.30), and acupuncture (19.21).

Table 3 Selected Linear Number Scale Questions from Survey Presented to Rural Family Medicine Residents. For Ease of Presentation, We Shortened the Items. Full Survey Can Be Viewed in Supplemental Document 1

Discussion

This was the first study to evaluate the knowledge of neuromodulation, an evidence-based therapy for post-laminectomy syndrome, among rural family medicine residents. Through our survey study, we found that slightly less than half of rural family medicine residents have made the diagnosis of post-laminectomy syndrome or failed back syndrome. Despite this, only one quarter of those have referred a patient for neuromodulation. We also noted that these residents rated their knowledge of neuromodulation below acupuncture, chronic opioid management, adjuvant medications, and epidural steroid injections despite mounting evidence of the effectiveness of neuromodulation for the treatment of this condition.

While the efficacy of neuromodulation has been demonstrated, this evidence-based therapy has not been widely adopted, particularly as a referral option for family medicine residents seeing patients with post-laminectomy syndrome. We feel that this finding is particularly important because many chronic pain patients are treated exclusively by their primary care physicians. This especially holds true in rural America and in rural areas around the globe. While randomized controlled trials are always needed to prove efficacy of novel treatment options, the movement of evidence-based practices (EBP) into routine clinical usage is not spontaneous and often takes focused, dedicated effort.18 It has been shown that an EBP require an average of seventeen years to be incorporated into routine clinical practice.19,20 Despite these averages, over half of proven, efficacious treatments never reach widespread clinical usage.19 This demonstrates that even the best clinical evidence does not guarantee any tangible public health impact, as seems to be the case with neuromodulation in certain contexts.

There are many potential reasons why there is not widespread referrals of patients with post-laminectomy syndrome to neuromodulators. Many primary care providers have historically treated chronic non-malignant pain with opioids.21 While the CDC guidelines have been effective at reducing average oral morphine equivalents, most academic family medicine physicians (88.4%) report feeling confident in their ability to prescribe opioids for non-malignant chronic pain.21,22 While the CDC guidelines do state that “nonpharmacologic therapy” is preferred for chronic pain treatment over opioids, the examples used in the manuscript do not include advanced pain procedures like radiofrequency ablation and neuromodulation.22 This could lead to a lack of inclusion of these therapies in treatment algorithms in primary care education programs not only in the United States but around The World. In addition, since very little neuromodulation literature is published in primary care or family medicine journals, the dissemination of this literature into these fields is unknown. Lastly, these authors have found that there is little crossover between the current fields of implementation science and neuromodulation in the currently published literature. We feel that the basic principles of implementation science would lend themselves to an increased uptake of this EBP.

Implementation science is defined as

“the scientific study of methods to promote the systematic uptake of research findings and other evidence based practices into routine practice, and, hence, to improve the quality and effectiveness of health services.18

This novel research field seeks to solve the lack of acceptance of an EBP by combining implementation interventions into a comprehensive implementation strategy that can be replicated in other institutions, health-care systems, or populations.23 In the Expert Recommendations for Implementing Change Project (ERIC), Powell et al lists seventy-three defined implementation strategies.24 Examples of implementation interventions include education/training, audit and feedback, performance incentives, electronic medical record based reminders, and academic detailing. The goal of implementation science research is to propose an implementation strategy would increase the uptake of an EBP like use of neuromodulation in patients with post-laminectomy syndrome with the hopes that this implementation strategy can be widely replicated. While this may represent a fundamental change in the way that research is conducted in the field of neuromodulation, these authors feel that incorporating these types of strategies could have far-reaching patient care implications. Implementation based neuromodulation research could fuel the universal, world-wide acceptance of neuromodulation as a first line treatment for proven indications-like post-laminectomy syndrome, complex regional pain syndrome, and others.

Conclusion

Despite high-level evidence that neuromodulation is an effective treatment for post-laminectomy/failed back syndrome, this study demonstrates that there is poor implementation of this practice by rural family medicine residents. While increased dissemination of this data through targeted education, lectures, and conferences may be helpful, we feel that the proven methods of implementation science research could be a large asset to the neuromodulation community. Ongoing discussion of how to better implement EBPs in neuromodulation is needed at practice, institutional, and society levels worldwide.

Data Sharing Statement

The data that support the findings of this study are available on request from the corresponding author.

Author Contributions

JG and CH conducted the data analysis and assembly for presentation in the document. JG prepared the manuscript draft with important intellectual input from CH, EP, and GC. JG, CH, EP, and GC provided editorial input. All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

The project described was supported by the Translational Research Institute (TRI), grant UL1 TR003107 through the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Disclosure

Dr. Goree has received consultant fees from Abbott and Stratus Medical. Dr. Goree has received research support paid to his institution from SPR Therapeutics and Mainstay Medical. Dr. Petersen has received consultant fees from Abbott/St. Jude Medical, Medtronic, Nevro, Neuros, Saluda, Vertos, Presidio, and ReNeuron. Dr. Petersen had received research and education support paid to her institution from Nevro, Neuros Medical, SPR, ReNeuron, and Medtronic, and Saluda. Dr. Petersen has stock options in SynerFuse and neuro.42. The authors report no other conflicts of interest in this work.

References

1. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715–724. doi:10.1016/j.jpain.2012.03.009

2. Murphy KR, Han JL, Yang S, et al. Prevalence of specific types of pain diagnoses in a sample of United States Adults. Pain Physician. 2017;20(2):E257–E268.

3. Chan CW, Peng P. Failed back surgery syndrome. Pain Med. 2011;12(4):577–606. doi:10.1111/j.1526-4637.2011.01089.x

4. Bailey JC, Kurklinsky S, Sletten CD, Osborne MD. The effectiveness of an intensive interdisciplinary pain rehabilitation program in the treatment of post-laminectomy syndrome in Patients who have failed spinal cord stimulation. Pain Med. 2018;19(2):385–392. doi:10.1093/pm/pnx060

5. Schug SA, Lavand’homme P, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2019;160(1):45–52. doi:10.1097/j.pain.0000000000001413

6. Christelis N, Simpson B, Russo M, et al. Persistent spinal pain syndrome: a proposal for failed back surgery syndrome and ICD-11. Pain Med. 2021;22(4):807–818. doi:10.1093/pm/pnab015

7. Lehmann TR, LaRocca HS. Repeat lumbar surgery. A review of patients with failure from previous lumbar surgery treated by spinal canal exploration and lumbar spinal fusion. Spine. 1981;6(6):615–619. doi:10.1097/00007632-198111000-00014

8. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–978. doi:10.1126/science.150.3699.971

9. Norman SC, J Mortimer, J Reswick, et al. Electrical inhibition of pain by stimulation of the dorsal columns. Anesth Analg. 1967;46(4). doi:10.1213/00000539-196707000-00025

10. North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery. 2005;56(1):98–107. doi:10.1227/01.neu.0000144839.65524.e0

11. Vakkala M, Järvimäki V, Kautiainen H, Haanpää M, Alahuhta S. Incidence and predictive factors of spinal cord stimulation treatment after lumbar spine surgery. J Pain Res. 2017;10:2405–2411. doi:10.2147/JPR.S143633

12. Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1–2):179–188. doi:10.1016/j.pain.2007.07.028

13. Mekhail N, Levy RM, Deer TR, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19(2):123–134. doi:10.1016/S1474-4422(19)30414-4

14. Deer T, Slavin KV, Amirdelfan K, et al. Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodulation. 2018;21(1):56–66. doi:10.1111/ner.12698

15. Kapural L, Yu C, Doust MW, et al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123(4):851–860. doi:10.1097/ALN.0000000000000774

16. Ballantyne JC. Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions. Anesth Analg. 2017;125(5):1769–1778. doi:10.1213/ANE.0000000000002500

17. Cooper TE, Fisher E, Gray AL, et al. Opioids for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev. 2017;7(7):CD012538. doi:10.1002/14651858.CD012538.pub2

18. Bauer MS, Damschroder L, Hagedorn H, et al. An introduction to implementation science for the non-specialist. BMC Psychol. 2015;3(1). doi:10.1186/s40359-015-0089-9

19. Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Yearbook of Medical Informatics. Stuttgart: Schattauer; 2000:65–70.

20. Morris ZS, Wooding S, Grant J. The answer is 17 years, What is the question: understanding time lags in translational research. J Roy Soc Med. 2011;104(12):510–520. doi:10.1258/jrsm.2011.110180

21. Macerollo AA, Mack DO, Oza R, Bennett IM, Wallace LS. Academic family medicine physicians’ confidence and comfort with opioid analgesic prescribing for patients with chronic nonmalignant pain. J Opioid Manag. 2014;10(4):255–261. doi:10.5055/jom.2014.0213

22. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–United States, 2016. JAMA. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464

23. USVA QUERI (US Department of Veterans Affairs: Quality Enhancement Research Initiative, QUERI). Available from: www.queri.research.va.gov/implementation. Accessed April 6, 2020.

24. Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10(1). doi:10.1186/s13012-015-0209-1

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.